Clinical Trial Update: A 16-Week Study of Pirenzepine or Placebo to Treat HIV-Associated Distal Sensory Polyneuropathy in Patients With HIV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing pirenzepine versus placebo for HIV-associated distal sensory polyneuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Polyneuropathy

Drugs mentioned

• pirenzepine (pirenzepine)

Snippet

Sponsor: WinSanTor, Inc | Conditions: HIV Associated Polyneuropathy | Phase 2 | Status: COMPLETED